Workflow
精华油
icon
Search documents
国泰海通:受销售策略调整及春节错期影响 美妆销售淡季边际改善
智通财经网· 2026-02-09 07:30
Core Viewpoint - The beauty industry is expected to maintain steady growth in 2026, driven by product innovation and the rise of domestic brands, with Douyin's beauty GMV projected to grow over 20% year-on-year in January 2026, reflecting a marginal improvement during the off-season due to brand efforts in daily sales and self-broadcasting, alongside the impact of the Spring Festival timing [1][2]. Group 1: Strong Product and Brand Momentum - Companies with strong product and brand momentum are expected to achieve high growth through new product launches and category expansions, such as Ruoyuchen, which is focusing on high-end household cleaning and health products [3]. - Beijiaojie is maintaining stable performance in oral care and is expected to benefit from the trend of AKK ingredients in its probiotic raw material business [3]. - Maogeping is positioned as a high-end brand with ongoing expansion in offline counters and online sales, anticipating rapid growth across multiple product lines [3]. - Linqingxuan is benefiting from the trend of oil-based skincare, with its flagship essence oil performing well and new products showing promise [3]. - Shangmei Co. is expanding its main brand Han Shu and sub-brands, with strong growth expected from key products [3]. Group 2: Leading Brands with Strong Asset Value - Beitanie has been actively adjusting its channel and inventory mechanisms since 2025, leading to product structure upgrades and profit recovery, with strong GMV growth in January 2026 [4]. - Proya is expected to have a clear new product strategy in 2026, launching several key products and expanding its sub-brands to drive steady growth [4]. Investment Recommendations - Companies with strong fundamentals and high growth potential recommended for increased holdings include Ruoyuchen, Beijiaojie, Maogeping, Linqingxuan, and Shangmei Co. [5]. - Companies showing signs of bottom improvement include Beitanie, Proya, Dengkang Oral, Shanghai Jahwa, and Runben Co. [5].
美妆行业更新:美护修复,关注高成长与边际改善
Investment Rating - The report assigns an "Accumulate" rating for the cosmetics industry, indicating a positive outlook for selected companies within the sector [5]. Core Insights - The beauty industry is expected to maintain steady growth in 2026, driven by product innovation and the rising trend of domestic brands. The report suggests a bottom-up selection of high-growth products and brands with strong potential, as well as companies that exhibit resilience amid product and channel changes [2][5]. Summary by Sections Industry Overview - The report highlights that the cosmetics sales during the off-peak season have shown marginal improvement. It suggests focusing on products and brands with strong growth momentum and resilience in the face of changing product and channel dynamics [2]. Key Investment Points - The report identifies two main lines of investment: 1. **High-Growth Companies**: Companies like RuYuchen, BeiJiaJie, MaoGePing, LinQingXuan, and ShangMei are expected to perform well due to strong fundamentals and product innovation [5]. 2. **Brands with Strong Asset Value**: Companies such as BeiTaiNi and PoLaiYa are anticipated to see marginal improvements following adjustments in their channels and product structures [5]. Market Performance - According to data from the National Bureau of Statistics, the retail sales of cosmetics in December 2025 grew by 8.8% year-on-year, significantly outpacing the overall retail growth of 0.9%. The annual retail sales for cosmetics in 2025 reached 465.3 billion yuan, reflecting a 5.1% year-on-year increase [5]. Company Valuations - The report provides a valuation table for key companies, indicating their earnings per share (EPS) and price-to-earnings (PE) ratios for 2025E, 2026E, and 2027E. For instance, RuYuchen has an EPS of 0.59 yuan for 2025E with a PE of 60, while BeiTaiNi has an EPS of 1.10 yuan for 2025E with a PE of 43 [7].
全链”上市!美妆企业争做“第一股
Shen Zhen Shang Bao· 2026-01-16 00:33
Core Viewpoint - The beauty industry is experiencing a surge in IPO activities, with over 41 companies aiming for public listings in 2025, while simultaneously facing challenges with 10 companies exiting the capital market [1][4]. Group 1: IPO Activities - In December, Lin Qingxuan successfully listed on the Hong Kong Stock Exchange, marking it as the first high-end domestic skincare stock in Hong Kong [1]. - Major domestic beauty brands like Naturals, Proya, and Marubi are also pursuing listings, with Proya and Marubi aiming for dual listings in both A-shares and H-shares [1]. - The IPO wave includes a diverse range of companies across the beauty supply chain, including raw material suppliers and packaging companies, with 8 companies like Vicky Technology and Jiakai Biotechnology also in the IPO race [2]. Group 2: Market Challenges - Despite the IPO enthusiasm, 10 beauty-related companies have exited the A-share or New Third Board markets, indicating a stringent selection process by capital markets [4]. - Many companies, including Naturals and Vicky Technology, have faced delays in their IPO processes, often remaining in the application or advisory stages [4]. - The third-quarter report for 2025 shows that only a few beauty companies have maintained revenue growth, with many facing significant operational pressures [5]. Group 3: Industry Dynamics - The beauty industry is characterized by a dual trend of IPO excitement and market exits, highlighting the need for companies to address issues such as heavy reliance on marketing over research and development [6]. - Companies like Naturals have reported high marketing costs, with sales and marketing expenses reaching 57% of revenue, while R&D investment has decreased significantly [6]. - The reliance on flagship products, such as Lin Qingxuan's dependence on its essence oil, poses additional challenges for sustainable growth [7].
“全链”上市!美妆企业争做“第一股”
Shen Zhen Shang Bao· 2026-01-15 17:51
Core Viewpoint - The beauty industry is experiencing a surge in IPO activities, with over 41 beauty-related companies aiming for IPOs in 2025, indicating a robust interest in capital markets within this sector [2][3]. Group 1: IPO Activities - In December 2024, Lin Qingxuan successfully listed on the Hong Kong Stock Exchange, marking it as the first high-end domestic skincare stock in Hong Kong [2]. - Major domestic beauty brands such as Naturals, Proya, and Marubi have initiated their IPO processes, with Proya and Marubi already listed on A-shares, aiming for a dual listing in Hong Kong [2][3]. - The IPO wave includes a diverse range of companies from the beauty supply chain, including raw material suppliers, packaging companies, and brand operators [2][3]. Group 2: Market Dynamics - Since the end of 2024, there has been a notable trend of companies exiting the capital market, with 10 beauty-related companies having withdrawn from A-shares or the New Third Board [5]. - Many companies are facing delays in their IPO processes, with some, like Naturals and Weiqi Technology, still in the application or advisory stages despite having significant revenue [5][6]. - The A-share beauty companies reported a total revenue of 27.707 billion yuan and a net profit of 3.753 billion yuan in the first three quarters of 2025, with Proya leading at 7.098 billion yuan, showing only a slight growth of 1.89% year-on-year [6]. Group 3: Challenges in the Industry - The beauty industry is grappling with challenges such as an overemphasis on marketing at the expense of research and development, as evidenced by Naturals' marketing costs significantly outweighing its R&D investments [7][8]. - Companies like Lin Qingxuan are heavily reliant on a single product category for revenue, which poses risks to their long-term growth and stability [8]. - The current market environment is increasingly selective, favoring companies with solid market foundations, clear brand positioning, and strong technological barriers [5][7].
“全链”上市!美妆企业争做“第一股” 去年40多家相关企业冲刺IPO,也有10家告别资本市场
Shen Zhen Shang Bao· 2026-01-15 17:43
Core Insights - The beauty industry is experiencing a surge in IPO activity, with over 41 beauty-related companies aiming for IPOs since 2025, covering various segments of the supply chain [1][2] - The trend of companies seeking to become the "first stock" in their respective niches is prominent, with several brands targeting specific categories such as whitening and anti-hair loss [3] - Despite the IPO enthusiasm, there are challenges as 10 beauty-related companies have exited the capital market, indicating a stricter selection process by investors [4] IPO Activity - Numerous companies are preparing for IPOs, with notable brands like Gu Yu, Lin Qingxuan, and Plant Doctor submitting applications in 2025 [2][3] - The IPO wave includes not only brand companies but also raw material suppliers and packaging companies, indicating a comprehensive industry interest [2] - Specific milestones include Lin Qingxuan becoming the first high-end domestic skincare stock in Hong Kong and other brands aiming for dual listings [1][2] Financial Performance - In the first three quarters of 2025, eight listed beauty companies reported a total revenue of 27.707 billion yuan and a net profit of 3.753 billion yuan [5] - The leading company, Proya, achieved a revenue of 7.098 billion yuan, showing only a slight year-on-year increase of 1.89%, while Shanghai Jahwa reported a 10.83% growth [5] Industry Challenges - The beauty industry faces significant challenges, including a heavy reliance on marketing over research and development, which could hinder long-term growth [6][7] - Companies like Natural Hall and Lin Qingxuan have shown a concerning trend of low R&D investment compared to their marketing expenditures, with R&D costs declining as a percentage of revenue [6][7] - The industry's dependency on flagship products poses risks, as seen with Lin Qingxuan's reliance on its essence oil for revenue [7]
IPO周报|沐曦正式登陆科创板;壁仞科技、天数智芯通过港交所聆讯
IPO早知道· 2025-12-21 12:45
Core Viewpoint - The article provides an overview of recent IPO activities across Hong Kong, the US, and A-shares, highlighting several companies preparing for their public listings and their respective market positions. Group 1: Muxi Integrated Circuit - Muxi Integrated Circuit (Shanghai) Co., Ltd. officially listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 17, 2025, with the stock code "688802" [3] - Founded in 2020, Muxi is a leading domestic high-performance general-purpose GPU product company, focusing on the research, design, and sales of GPUs for AI training, inference, general computing, and graphics rendering [3] - Muxi's GPU products have achieved cumulative sales of over 25,000 units by the end of March 2025, with a revenue compound growth rate of 4074.52% over the past three years, and revenue of 915 million yuan in the first half of this year [5] Group 2: Woan Robotics - Woan Robotics (Shenzhen) Co., Ltd. plans to officially list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "6600" [7] - The company aims to become the "first stock of AI-embodied household robots," with an IPO market valuation between 14 billion and 18 billion HKD, raising up to 1.8 billion HKD [8] - Woan Robotics is recognized as the only company globally to comprehensively layout AI-embodied household robot systems, holding an 11.9% market share in the sector by 2024 [10] Group 3: Xunce Technology - Xunce Technology plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "3317," marking it as the first company in China's AI data sector to complete an IPO [12] - The company aims to raise up to 1.2375 billion HKD through its IPO, with a focus on real-time data infrastructure and analysis solutions [12] - Xunce Technology's real-time data solutions are noted for their speed and consistency, optimizing business efficiency and flexibility [14] Group 4: InSilico Medicine - InSilico Medicine plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "3696," aiming to raise up to 2.3 billion HKD [16] - The company is recognized as the largest biotech IPO in Hong Kong this year, with a focus on AI-driven drug development across various industries [17] - InSilico's core asset, Rentosertib, is a first-in-class candidate drug for idiopathic pulmonary fibrosis, showcasing the company's innovative capabilities [18] Group 5: Linqingxuan - Linqingxuan Cosmetics Group plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "2657," aiming to raise over 1 billion HKD [21] - The company is positioned as the leading high-end domestic skincare brand in China, with a complete product matrix in anti-wrinkle and firming skincare [22] - Linqingxuan ranks first among all domestic high-end skincare brands in China by retail revenue in 2024 [22] Group 6: 51WORLD - 51WORLD plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "6651," aiming to become the "first stock of Physical AI" [24] - The company has established a comprehensive technology capability in Physical AI, with products applied in various industries globally [24] - 51WORLD's revenue has shown significant growth, with a 63.6% increase in the first half of this year compared to the same period last year [26] Group 7: Qingsong Health Group - Qingsong Health Group plans to list on the Hong Kong Stock Exchange on December 23, 2025, with the stock code "2661," aiming to raise over 600 million HKD [28] - The company operates as a one-stop digital health and insurance service platform, covering various health-related services [28] - Qingsong Health Group's revenue has grown significantly, with an 84.7% increase in the first half of this year compared to the previous year [29] Group 8: Biran Technology - Biran Technology has passed the hearing for its listing on the Hong Kong Stock Exchange, focusing on general intelligent computing solutions [31] - The company has shown strong growth potential, with significant sales agreements in place and a focus on AI data centers and telecommunications [32] Group 9: Zhipu Technology - Zhipu Technology has passed the hearing for its listing on the Hong Kong Stock Exchange, aiming to become the "first stock of global large models" [35] - The company has achieved significant revenue growth, with a compound annual growth rate of 130% from 2022 to 2024 [36] Group 10: Tiandu Intelligent Chip - Tiandu Intelligent Chip has passed the hearing for its listing on the Hong Kong Stock Exchange, focusing on general-purpose GPU chips [38] - The company has seen a significant increase in customer numbers and product shipments, reflecting strong market recognition [39]
林清轩更新招股书12天后通过聆讯,孙来春、高宏旗薪金大幅上调
Sou Hu Cai Jing· 2025-12-15 10:40
Core Viewpoint - Lin Qingxuan Biotechnology Co., Ltd. is preparing for an IPO, having submitted an updated prospectus and is ranked first among domestic and international high-end skincare brands in China by store count [2] Financial Performance - In the first half of 2025, Lin Qingxuan's revenue increased by 93% to 1.052 billion RMB, and net profit rose by 120% to 182 million RMB, with a gross margin exceeding 82% [3] - Total revenue for the years 2022, 2023, and 2024 was 691.5 million RMB, 805 million RMB, and 1.21 billion RMB respectively, while net profit transitioned from a loss of 5.93 million RMB in 2022 to a profit of 845.18 million RMB in 2023 and 1.87 billion RMB in 2024 [5] Store Expansion and Market Position - As of June 30, 2025, Lin Qingxuan operates 554 stores nationwide, with over 95% located in shopping malls, indicating a strong retail presence [2] - The company is recognized as the leading brand in China for both domestic and international high-end skincare products based on the total number of stores [2] Product Performance - The highest revenue contribution comes from essence oils, followed by creams and masks, with product prices ranging from 200 to 800 RMB [5] - The increase in revenue is attributed to repeat purchases from existing customers and the acquisition of new customers, alongside effective promotional strategies and cost control measures [4]
行业周报:柬埔寨公布对中免签政策,蜜雪、古茗进军早餐-20251207
KAIYUAN SECURITIES· 2025-12-07 14:41
Investment Rating - The report maintains a "Positive" investment rating for the industry [1] Core Insights - The report highlights the growth in tourism between China and Cambodia, driven by the new visa-free policy, which is expected to boost tourist flows [5][15] - The breakfast market in China is identified as a significant opportunity, with major brands like Mixue and Guoming entering the segment [6][33] - The education sector is experiencing a shift towards vocational training due to declining numbers in traditional higher education applications, emphasizing employment-oriented education [39][44] - Lin Qingxuan, a high-end domestic skincare brand, is showing strong growth in both online and offline sales, with a notable increase in revenue and profit margins [45][50] Summary by Sections 1. Travel and Tourism - Cambodia has implemented a visa-free policy for Chinese citizens, expected to increase tourist numbers significantly, with a 45% year-on-year increase in Chinese tourists from January to October 2025 [5][15] - In November 2025, Hainan's duty-free shopping reached 2.38 billion yuan, a 27.1% increase year-on-year, despite a slight decrease in shopping visitors [23][24] 2. Breakfast Market - The breakfast market in China is valued at approximately 1.7 trillion yuan, with the external breakfast market estimated between 700 to 800 billion yuan [6][33] - Mixue has launched breakfast offerings in several cities, targeting consumers with affordable pricing [37][38] 3. Education Sector - The number of students taking the national college entrance examination has decreased for the first time in eight years, with a significant drop in graduate school applications [39][40] - Vocational education is gaining traction as students seek better employment outcomes, with a reported 95%+ employment rate in vocational programs [44] 4. Skincare Industry - Lin Qingxuan reported a revenue of 1.05 billion yuan in the first half of 2025, marking a 98.3% year-on-year increase, with online sales growing significantly [45][47] - The brand's product mix includes a high proportion of premium skincare items, contributing to improved profit margins [50][55] 5. Market Performance - The Hong Kong stock market saw the consumer services and media sectors underperforming, while the retail sector outperformed the market [59][65] - Notable stock performances included significant gains in retail and education sectors, with specific companies like Liufu Group and Gaoxin Retail leading the gains [65][66]
东北兄弟卖美妆,6个月收入10亿,冲刺国货高端护肤第一股
Core Viewpoint - Lin Qingxuan, a domestic beauty brand, has resubmitted its IPO application to the Hong Kong Stock Exchange, highlighting significant revenue growth and a rebranding to position itself as a high-end skincare brand in China [1][2]. Group 1: Company Performance - In the first half of 2025, Lin Qingxuan reported total revenue of 1.05 billion RMB, representing a remarkable year-on-year growth of 98% compared to the first half of 2024 [1]. - The company's gross margin reached 82.4% in the first half of 2025, up from 81.9% in the same period of 2024, indicating strong pricing power and operational efficiency [3]. - The revenue contribution from the essence oil product line accounted for 45.5% of total revenue in the first half of 2025, showing a consistent upward trend in its importance to overall sales [2]. Group 2: Market Positioning - Lin Qingxuan emphasizes its high-end positioning, ranking first among domestic high-end skincare brands in China by retail sales in 2024, and is the only domestic brand among the top 15 high-end skincare brands [2]. - The high-end skincare market in China is relatively concentrated, with the top 15 brands holding 66.1% of the market share, indicating a competitive landscape [2]. Group 3: Marketing and Sales Strategy - The company has significantly increased its sales and distribution expenses, which rose by 100.2% to 580.6 million RMB in the first half of 2025, driven by enhanced online and offline marketing activities [4]. - Lin Qingxuan's marketing strategy has been questioned for being "heavy on marketing and light on R&D," but industry experts suggest that marketing and brand strength are crucial competitive factors in the cosmetics industry [3]. Group 4: Investment and Shareholding - The founder, Sun Laichun, holds 38.21% of the shares directly and approximately 79.27% in total, indicating strong founder control [5]. - Notable external investors include Yagao Fashion, Country Garden Venture Capital, and others, with Yagao holding 4.49% of the shares [5]. - Recent share acquisitions before the IPO have led to an estimated pre-IPO valuation of approximately 3.846 billion RMB for Lin Qingxuan [6]. Group 5: Industry Trends - The trend of domestic beauty brands pursuing IPOs in Hong Kong has intensified, with Lin Qingxuan following other brands like Natural Hall and Proya, reflecting a strategic move to access capital markets for growth [7]. - The domestic cosmetics market is expected to see increased demand for plant-based essential oils, indicating a potential growth area in the coming years [8].
东北兄弟卖美妆,6个月收入10亿,冲刺国货高端护肤第一股
21世纪经济报道· 2025-12-06 10:24
Core Viewpoint - Lin Qingxuan, a domestic beauty brand, has resubmitted its IPO application to the Hong Kong Stock Exchange, highlighting a significant revenue growth of 98% year-on-year for the first half of 2025, reaching 1.05 billion yuan [1]. Company Overview - Founded in 2003 and headquartered in Shanghai, Lin Qingxuan focuses on high-end anti-aging skincare products, with core product prices ranging from 200 to 800 yuan [3]. - The company has rebranded itself from "Shanghai Lin Qingxuan Biotechnology Co., Ltd." to "Shanghai Lin Qingxuan Cosmetics Group Co., Ltd." to align with its positioning as a high-end domestic skincare brand [2]. Market Position and Performance - Lin Qingxuan ranks first among domestic high-end skincare brands in China by retail sales, and is the only domestic brand among the top 15 high-end skincare brands [3]. - The high-end skincare market in China is concentrated, with the top 15 brands holding 66.1% of the market share [3]. - The company's revenue from its essence oil product line accounted for 45.5% of total revenue in the first half of 2025, showing a rising trend from previous years [3]. Financial Metrics - Lin Qingxuan achieved a gross margin of 82.4% in the first half of 2025, up from 81.9% in the same period of 2024, indicating strong pricing power [4]. - Sales and distribution expenses increased significantly, from 290.1 million yuan in the first half of 2024 to 580.6 million yuan in the first half of 2025, primarily due to increased marketing activities [4]. Investment and Shareholding - The founder, Sun Laichun, holds 38.21% of the shares directly and approximately 79.27% in total, making him the largest shareholder [6]. - External investors include prominent names such as Yagao Fashion and Country Garden Venture Capital, with Yagao holding 4.49% of the shares [6]. Industry Trends - The trend of domestic beauty brands going public in Hong Kong is increasing, with Lin Qingxuan following other brands like Natural Hall and Proya in seeking capital for growth [9]. - The domestic beauty market is expected to see a shift towards plant-based essential oils, indicating a growing consumer demand in the coming years [10].